Background
==========

Aortic cross-clamping during bypass grafting in patients with abdominal aorta aneurysms (AAA) leads to development of ischemia-reperfusion injury. Previous studies have shown that increased production of reactive oxygen species (ROS), such as superoxide anions, hydroxyl radicals, or hydrogen peroxide, plays a major role in cellular damage during post-ischemic reperfusion \[[@b1-medscimonit-20-2453],[@b2-medscimonit-20-2453]\]. Free radicals can participate in reduction-oxidation reactions, initiate lipid oxidation, degrade nucleic acids and membrane proteins, and increase endothelial adhesion molecule synthesis. However, free radicals as a result of the aortic cross-clamping during the surgical reconstruction, induce proinflammatory cytokines and chemokines \[[@b3-medscimonit-20-2453]\]. The synthesis of cytokines during the inflammatory processes generates an increase in concentrations of acute-phase proteins as a response to the tissue destruction \[[@b4-medscimonit-20-2453]\].

Endogenous antioxidant enzymes -- superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), and heme oxygenase (HO) -- have been shown to prevent skeletal muscle ischemia reperfusion injury by different mechanisms inhibiting ROS activity \[[@b5-medscimonit-20-2453]\]. When a bypass graft patient develops imbalance between free radicals and antioxidants, it has been shown that it leads to oxidative tissue damage. In patients undergoing AAA bypass grafting, it is possible to reduce oxidative stress and cellular damage by introducing different types of antioxidant treatment such as vitamin E and C, statin, xanthine oxidase, or mannitol. Several reports have described cases of elective AAA patients in whom reperfusion during bypass grafting led to oxygen free radicals production resulting in lipid peroxidation, especially in rupture AAA \[[@b6-medscimonit-20-2453]--[@b9-medscimonit-20-2453]\]. However, there have been no comparative studies on production and inhibition of ROS in patients with AAA and aortoiliac occlusive disease (AIOD) with critical and moderate ischemia.

Identification of free radicals is commonly investigated by using indirect methods and measurements, such as conjugated dienes, hydroperoxides, and aldehydes \[[@b10-medscimonit-20-2453]\]. Electron paramagnetic resonance spectroscopy (EPR) spin-trapping has been considered a valuable method because it directly measures free radicals production \[[@b11-medscimonit-20-2453]\]. EPR is widely used in investigating the structure and dynamics of paramagnetic centers and free radicals that have 1 or more unpaired electrons. The main advantages of EPR spectroscopy are simple preparation of the sample, short time of measurement, and high sensitivity. These advantages are why EPR is becoming widely used in studies of biological samples. This method is based on interaction of an external magnetic field with magnetic moments of unpaired electrons in a sample, which leads to splitting the electron energy levels. An EPR signal is observed when the quantum of the electromagnetic wave energy (hν) incident on the sample is equal to the energy difference between the energy levels, which is described by the resonance condition:
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where g is the so-called g-factor, μ~B~ is the Bohr magneton, and B~0~ is the magnetic induction of an external magnetic field. The value of the g-factor can provide information about the kind of paramagnetic center, and the intensity of EPR signals is directly proportional to the free radical concentration in a sample. For this reason, many biological substances have been investigated by this method \[[@b12-medscimonit-20-2453]--[@b14-medscimonit-20-2453]\].

Therefore, in the present study the technique of electron paramagnetic resonance spectroscopy was used to examine the rate of free radicals generation in relation to the activity of antioxidant enzymes and proinflammatory cytokines production in AAA and AIOD patients treated surgically.

Material and Methods
====================

The study was performed in a group of 32 AAA patients (mean age 66.78±7.64 years, 28 men and 4 women) and 25 AIOD patients (mean age 61.12±6.99 years, 19 men and 6 women) (Rutherford Stage 3). AAA and AIOD were diagnosed before surgery using Doppler ultrasonography, computed tomography, or arteriography. The mean internal diameter of the aneurysms was 6.58±1.28 cm. Our patients were examined so as to diagnose any concomitant diseases and provide proper application of treatment to prevent surgical complications. The perioperative data (particularly regarding cardiovascular risk factors), concomitant diseases, and medications are shown in [Table 1](#t1-medscimonit-20-2453){ref-type="table"}. All patients on the day of surgery were on statins but only 16 AAA patients (50%) and 21 AIOD patients (84%) received statins for at least 3 months before surgical treatment. Additionally, administration of the indicated oral medications, particularly β blockers and ACE inhibitors, was continued until the reconstruction.

Preoperatively, an epidural catheter with bupivacaine was introduced and preoxygenation was performed prior to induction of general anesthesia. Propofol and sevoflurane were administered to all the patients to maintain anesthesia. In 5 AAA patients, simple prosthetic reconstruction of infrarenal aortic aneurysm was performed, and 27 patients who had additional iliac artery aneurysms underwent aortoiliac bifurcated graft implantation.

The treatment of choice in the AIOD patients was implantation of an aorto-bifemoral bypass graft. Before cross-clamping of the abdominal aorta, each patient received intravenously 5000 units of heparin and 0.5 g/kg mannitol. At the beginning of the reperfusion, brief clamping and declamping of the abdominal aorta was performed once or twice before starting the typical reperfusion. This procedure facilitates correction of blood pressure and proper fluid replacement before and during early-phase reperfusion.

Venous blood samples were collected before the induction of anesthesia, before the clamp removal, 5 min after the reperfusion of first and second leg, and 24 h after the operation. The mean intervals between the blood flow reconstruction in first and second legs were: AAA 11.03±6.53 and AIOD 11.80±6.23 min.

For EPR measurements, a sample of 0.5 ml of the patient's blood was mixed with 2 ml of nitrosobenzene solution immediately after the blood samples collection and divided into 3 identical samples immediately after collection. After 1 min, these samples were placed in a Dewar flask with liquid nitrogen (77 K) and stored. The nitrosobenzene spin trap (C~6~H~5~NO) (Aldrich Chemical Co.) was used in the experiments. We dissolved 107 mg of nitrosobenzene in 3 ml of methanol CH~3~OH, and 97 ml of distilled water was added. The measurements were made with a Bruker EMX-10 X-band (9.4 GHz) spectrometer with magnetic field second modulation frequency of 100 kHz. The EPR spectra were recorded at 170 K temperature in a sweep width of 20 mT. Low temperatures were maintained by using an ER 4131VT Bruker temperature controller. The following time parameters were applied: a sweep time of 10.48 s and a time constant of 20.48 ms. The standard weak pitch sample with concentration of free radicals equal to 2×10^13^ spins was used to determine the concentration of free radicals in the samples of blood. The concentration of free radicals was calculated from integrated intensity of free radical signals. Customarily, the results are given in relative values of intensity changes because it has less error. The value of 10 000 a.u. corresponds to about 10^15^ spins in a sample.

GPx, SOD, CRP, IL-6, TNF-α, ox-LDL, HO-1, and TBARS assessment was conducted with use of standardized commercially available methods ([Appendix 1](#app1-medscimonit-20-2453){ref-type="app"}).

Ethical approval
----------------

Institutional regulatory board approval 1021/08 16^th^ October 2008.

Statistical analysis
--------------------

The results were analyzed by a non-parametric Mann-Whitney U test. To compare the median values between the 2 dependent groups at different times before and following surgical treatment, the Wilcoxon matched-pairs signed-ranks test was applied with Bonferroni correction. Spearman's correlations were performed for correlation analyses. Statistical significance was accepted at the level of P\<0.05.

Results
=======

The highest radicals concentration was observed after aortic clamp removal. The measured median values of free radicals by EPR before induction of anesthesia, pre-release of aortic clamp, 5 min after aortic clamp removal, and reperfusion of first leg, 5 min after ipsilateral branch of prosthesis clamp removal, and reperfusion of second leg and 24 h after the operation are summarized in [Table 2](#t2-medscimonit-20-2453){ref-type="table"}. Median values of the free radicals revealed a significant elevation after 5 min of the reperfusion of the first leg in surgical treatment of patients with AAA. In both groups of patients, 24 h after surgery, free radicals concentration decreased to a value similar to that before the operation. The values of MDA 5 min after aortic clamp removal and reperfusion of the first leg and also after the reperfusion of the second leg were increased significantly in AAA ([Table 3](#t3-medscimonit-20-2453){ref-type="table"}). The changes in free radicals level significantly was correlated with the time of aortic cross-clamping after the reperfusion of the first and second leg in patients with AAA (r=0.7; r=0.47). Typical spectra of AAA samples are presented in [Figure 1](#f1-medscimonit-20-2453){ref-type="fig"}.

The median values of ox-LDL concentration in AAA patients were significantly decreased 5 min after reperfusion of the first leg (32.99 U/L, range: 14.09--77.12) and 5 min after reperfusion of the second leg (26.75 U/L, range: 11.56--82.12) as well as 24 h after the operation (25.85U/L, range; 14.29--49.70) in comparison to the results obtained before the operation (42.27 U/L, range: 25.53--127.78). In the patients with AIOD, decreased values of ox-LDL concentration after reperfusion of the first leg: 30.13 U/L (12.05--116.19) and second leg: 27.16 U/L (9.92--55.33) and also 24 h after the operation: 27.18 U/L (9.38--57.30) were not significant as compared to the value observed before the operation 37.77 U/L (17.10--101.36).

The concentrations of HO-1, and the activity of GPx and SOD in AAA and AIOD before and during the surgical treatment are summarized in [Table 4](#t4-medscimonit-20-2453){ref-type="table"}.

The following concentration medians of CRP, IL-6, and TNF-alfa before the operation were found in the AAA patients: 1.21 mg/l (0.2--3.24), 84.24 pg/ml (9.49--241.31), 3.77 pg/ml (0.44--58.45), respectively, and in the AIOD patients: 2.37 mg/l (1.53--6.84), 71.25 pg/ml (60.89--141.91), 3.13 pg/ml (0.39--24.85), respectively. Twenty-four hours after the surgery, inflammatory markers increased in the patients with AAA: CRP was 14.76 ml/l (0.23--38.55), IL-6 was 141.22 pg/ml (84.3--591.03), and TNF-alfa was 6.82 pg/ml (1.76--80.01). In the patients with AIOD, CRP was 18.44 mg/l (2.56--33.14), IL-6 was 184.1 pg/ml (128.46--448.03), and TNF-alfa was 7.74 pg/ml (1.74--74.74).

Discussion
==========

Reperfusion of ischemic tissue due to cross-clamping of the aorta following AAA surgery induces an inflammatory response and free radicals production \[[@b15-medscimonit-20-2453]\]. Using EPR and the nitrosobenzene spin trap, we found a significant increase in the AAA group in free radicals production during reperfusion of the first leg 5 min after the aortic clamp removal, but after reconstruction of blood flow to the second leg this elevation of free radicals was insignificant. Detected radicals are probably extracellular. In patient with AOID in which there was lack of ischemic period related to cross-clamping, no significant elevated free radicals level was observed in the reperfusion phase. Twenty-four hours after the operation, free radicals decreased to the level observed before surgery in both groups. In the first minutes of reperfusion and reoxygenation of hypoxic tissue, high formation of oxygen radicals such as superoxide radicals (O^--^~2~) hydroxyl radicals (**.**OH) and hydrogen peroxide (16) is observed. The superoxide radicals in the reperfusion phase react with nitric oxide (NO) to generate peroxynitrite anions, which leads to the peroxidation of lipid and membrane proteins \[[@b17-medscimonit-20-2453]\]. Our data demonstrated significant increase in MDA concentration during reperfusion in the AAA group in comparison to the AOID group ([Table 3](#t3-medscimonit-20-2453){ref-type="table"}). MDA is a final product of lipid peroxidation, derived from polyunsaturated fatty acids, and is used for estimation of free radicals produced by ischemic and reperfused legs \[[@b18-medscimonit-20-2453]\].

Increased formation of reactive oxygen radicals during reperfusion is associated with different mechanisms of mitochondrial function, DNA damage, activation of apoptosis, destruction of cellular membranes, capillary perfusion failure, interstitial edema, and multiorgan dysfunction syndrome \[[@b19-medscimonit-20-2453]--[@b21-medscimonit-20-2453]\]. Severity of ischemia and reperfusion cellular injury is dependent on overproduction of free radicals, duration of ischemia, degree of surgical trauma, endogenous antioxidant capacity, and antioxidant therapy.

Our study demonstrated in the AAA group that among endogenous antioxidants HO-1 was significantly decreased 5 min after reperfusion of the first leg and the second leg. The beneficial role of HO-1 is related to protection of tissues against oxidative stress \[[@b22-medscimonit-20-2453]\]. In addition, GPx and SOD were decreased 5 min after reperfusion of the first leg in patients with AAA, but SOD was also decreased in early reperfusion in patients with AOID \[[@b23-medscimonit-20-2453]\]. SOD converts superoxide anions to hydrogen peroxide and then hydrogen peroxide is transformed to water and oxygen by glutathione peroxidase and catalase \[[@b24-medscimonit-20-2453]\]. This activity of the GPx, SOD, and HO-1 levels was associated with an increase in production of free radicals during reperfusion of the first leg. To protect tissue against injury from peripheral ischemia and reperfusion, anesthetic drugs such as propofol and sevoflurane were administered to all the patients. Propofol is chemically similar to α-tocopherol and may decrease MDA level and inhibit lipid peroxidation \[[@b25-medscimonit-20-2453]--[@b28-medscimonit-20-2453]\]. Other drugs useful in attenuating the production of free radicals (e.g., statins, β-blockers, ACE inhibitors, heparin, and mannitol) were administered according to [Table 1](#t1-medscimonit-20-2453){ref-type="table"} \[[@b29-medscimonit-20-2453]--[@b35-medscimonit-20-2453]\]. Reperfusion was performed in 2 different periods and separately in both legs, containing a smaller area of ischemic tissue and creating better conditions for antioxidant activity to prevent excessive free radicals generation. There are several studies proving that ischemic post-conditioning decreases free radicals production by limiting glutathione oxidation, as well as reducing the incidence of postoperative complications such as myocardial infarction and renal failure \[[@b36-medscimonit-20-2453]--[@b43-medscimonit-20-2453]\].

A significant increase in CRP, IL-6, and TNF-α observed 24 h after the surgical treatment of patients with AAA and AIOD may not only cause tissue injury during surgery, but also cause muscle ischemia during temporary aortic clamping and reperfusion. In our study, we observed lack of significant correlation between inflammatory markers and production of free radicals during reperfusion. These markers decreased 6--8 days after the aortic reconstructive surgery in uncomplicated cases (54). The endogenous antioxidant enzymes, as well as antioxidant treatment, as shown in our study, are able to prevent increase of ROS during aortoiliac reconstruction of AIOD patients due to lower production of free radicals in comparison to the AAA group, probably as the result of already established collateral flow. Collaterals maintain sufficient blood supply in AOID (Rutherford 3) patients during aortic cross-clamping.

Conclusions
===========

Using EPR spin-trapping, we demonstrated that in an early phase of reperfusion a temporarily elevated level of free radicals contributes to the reaction against ischemia of tissue, leading to a decrease in antioxidants such as HO-1, GPx, and SOD during surgical treatment of AAA. These elevated free radicals levels at the beginning of reperfusion decrease 24 h after surgery due to various endogenous antioxidants and antioxidant therapies. Surgical management including ischemic post-conditioning before starting reperfusion additionally make it possible to prevent development of irreversible tissue damage, morbidity, complications, and mortality in surgically treated patients.
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Methodology of GPx, SOD, CRP, IL-6, TNF-α, ox-LDL, HO-1 and TBARS assessment
============================================================================

The whole blood portion for the biochemical analysis of 100 μl was separated for the measurement of the GPx activity and 500 μl for the SOD activity. The plasma samples were prepared after centrifugation of the remaining whole blood at the speed 3000 rpm for 10 minutes at room temperature using a benchtop centrifuge (EBA20, Hettich, Gemany). Plasma samples were stored in a refrigerator at −20°C until assay.

C-Reactive Protein (CRP), interleukin-6 (Il-6) and TNF-α were measured by an immunometric assay based on a double-antibody sandwich technique (EIA kit, Cayman Chemical Company, Ann Arbor).

Samples for CRP were diluted (1:1000 and 1:16000) with ultra-pure water (Simplicity Millipore, 18.2 MΩcm^−1^) both, and introduced to the well of the microwell plate coated with a monoclonal antibody specific for human CRP. After addition of a horseradish peroxidase (HRP) labeled CRP monoclonal antibody, a sandwich with CRP molecule was formed. Tetramethylbenzidine (TMB) was used as a chromogenic substrate and after 15 minute incubation at room temperature in the dark the reaction was stopped by addition of an acid, and the product was measured spectrophotometrically at 450 nm. CRP concentration was calculated from the standard curve and expressed in mg/L.

For Il-6 assay plasma samples were diluted 1: 2 with EIA Buffer. Each well of the microplate was filled with plasma samples and an acetylcholinesterase: Fab' conjugate (AChE: Fab') was added to the wells coated with a monoclonal antibody specific for Il-6. After overnight incubation at 4°C of the enzymatic activity of AChE and the addition of Ellman's reagent, the product was determined spectrophotometrically at 450 nm periodically over four hours. Il-6 concentration was calculated from the standard curve obtained at the development time of 120 minutes, and expressed in pg/mL.

For TNF-α assay a specific monoclonal antibody and an acetylcholinesterase: Fab' conjugate (AChE: Fab') were added to the wells. After overnight incubation at 4°C, TNF-α was determined by measuring the enzymatic activity of the AChE with Ellman's reagent. The concentration of TNF-α was measured spectrophotometrically at 450 nm, calculated from the equation of the standard curve and expressed in pg/ml.

Oxidized low density lipoproteins (ox-LDL) in plasma were determined by using the ELISA kit (Mercodia AB, Uppsala, Sweden). An anti-oxidized LDL antibodies coated on the microplate wells and a peroxidase conjugated anti-human apolipoprotein B antibody added to the wells recognized the ox-LDL. The conjugate was reacting with a substrate and the product was measured at 450 nm. The concentration of ox-LDL was calculated based on the standard curve and expressed in U/L.

Glutathione peroxidase (GPx) activity was measured in the whole blood by using RANSEL kit (RANDOX Lab., UK). The method is based on the catalysis by GPx of the oxidation of reduced glutathione by cumene hydroperoxide to oxidized form (GSSG). Glutathione reductase (GR) and NADPH convert GSSG to its reduced form and NADPH to NADP^+^. GPx concentration was calculated based on the decrease in absorbance and expressed in U/L. Superoxide dismutase (SOD) activity was measured in whole blood by using RANSOD kit (RANDOX Lab., UK). The method employs xanthine and xanthine oxidase to generate superoxide anions and SOD activity is measured by the degree of inhibition of formazan dye formation. The activity of SOD was expressed in U/L of whole blood.

The HO-1 was quantitated with sandwich immunoassay EIA kit (Enzo Life Sciences). A mouse monoclonal antibody specific for HO-1 was pre-coated on the wells of the microplate. and HO-1 was captured by the immobilized antibody and detected with a HO-1 specific rabbit polyclonal antibody. The polyclonal antibody was subsequently bound by a horseradish peroxidase conjugated anti-rabbit IgG secondary antibody. The substrate added was TMB and the absorbance of the product was measured at 450 nm. HO-1 concentration was quantitated from a standard curve, and expressed in ng/mL.

Thiobarbituric Acid Reactive Substances (TBARS) concentration was measured by using a kit purchased at Cayman Chemical Company. The assay is based on the reaction of thiobarbituric acid with malondialdehyde (MDA) under high temperature (100°C) and in acidic solution. The product is measured spectrophotometrically at 530 nm, and the concentration of MDA was calculated from the standard curve and expressed in μM.

![EPR spectra typical for the patient's blood mixed with nitrosobenzene: (**A**) recorded at 170K, (**B**) at room temperature.](medscimonit-20-2453-g001){#f1-medscimonit-20-2453}

###### 

Characteristics of the studied AAA and AIOD patients.

  ------------------------------------------------------------------------------
  Parameters                          AAA (32 patients)\   AIOD (25 patients)\
                                      No. (%)              No. (%)
  ----------------------------------- -------------------- ---------------------
  Age \>70 years                      11 (34)              3 (12)

  Gender (male/female)                28/4                 19/6

  Current smoker                      16 (50)              18 (72)

  Hypertension                        17 (53)              11 (44)

  Hypercholesterolemia                12 (38)              12 (48)

  Coronary artery disease             13 (41)              10 (40)

  Previous myocardial infarction      8 (25)               5 (20)

  Cerebrovascular accident            1 (3)                1 (4)

  Type 2 diabetes                     9 (28)               6 (24)

  Renal insufficiency                 2 (6)                1 (4)

  Pulmonary disease                   3 (9)                1 (4)

  Medications                                              

   Aspirin                            32 (100)             25 (100)

   β-blocker                          16 (50)              11 (44)

   ACE                                17 (53)              10 (40)

   Statins 3 month                    16 (50)              21 (84)

   Intraoperative heparin             32 (100)             25 (100)

   Intraoperative mannitol            32 (100)             25 (100)

  Mean cross-clamp time (min)                              

   a) Before first leg reperfusion    51.47±15.24          51.12±15.36

   b) Before second leg reperfusion   62.50±17.80          62.92±18.84
  ------------------------------------------------------------------------------

###### 

Measurement of free radicals by EPR in blood of AAA and AIOD patients treated surgically.

  Blood sampling                          Values of free radicals measurement by EPR (a. u.) ×10^3^                         
  --------------------------------------- ----------------------------------------------------------- -------------- ------ ---------------
  Before induction of anesthesia          34.0                                                        (2.3--128.0)   30.0   (3.0--109.0)
  Pre-release of aortic clamp             42.0                                                        (6.0--144.0)   36.0   (10.0--118.0)
  5 min after first leg reperfusion       54.5                                                        (6.0--170.0)   55.0   (14.0--127.0)
  5 min after second leg reperfusion of   50.0                                                        (5.0--119.0)   43.0   (16.0--103.0)
  24 hours after operation                35.0                                                        (11.0--85.0)   39.0   (12.0--83.0)

AAA p-value \<0.05 I/III; III/V. AIOD p-value\<0.05 I/III; III/V.

###### 

Median values of malondialdehyde (MDA) in sera of AAA and AIOD patients treated surgically.

  Blood sampling                       Values of MDA (μmol/L) during surgical treatment                          
  ------------------------------------ -------------------------------------------------- --------------- ------ ---------------
  Before induction of anesthesia       5.30                                               (4.29--9.77)    4.98   (3.67--8.06)
  Pre-release of aortic clamp          5.36                                               (2.91--10.10)   5.18   (4.27--8.97)
  5 min after first leg reperfusion    5.64                                               (3.32--10.42)   5.90   (3.60--9.45)
  5 min after second leg reperfusion   5.58                                               (3.36--10.18)   5.48   (3.36--10.18)
  24 hours after operation             5.49                                               (3.0--9.58)     5.26   (3.00--8.36)

###### 

HO-1, GPx and SOD determination in patients with AAA and AIOD treated surgically.

               Values of antioxidants (HO-1, GPx, SOD)                                                                             
  ------------ ----------------------------------------- ------------------------ ----------------------- ------------------------ ------------------------
  HO-1 mg/ml   1.59 (1.04--3.25)                         1.45 (0.71--2.58)        1.25 (0.73--2.68)       1.32 (0.83--3.15)        2.7 (1.19--4.62)
  GPx U/L      3018 (1725--4587)                         2156 (1207--3725)        2035 (1000--3552)       2311 (1265--4139)        2552 (862--4242)
  SOD U/ml     154.24 (77.88--294.78)                    127.96 (40.8--205.4)     109.16 (10.0--185.12)   155.44 (15.76--222.04)   138.9 (89.24--205.4)
               **AIOD (N=25)**                                                                                                     
  HO-1 mg/ml   1.33 (0.86--2.5)                          0.95 (0.55--1.95)        0.98 (0.04--2.07)       1.01 (0.65--2.01)        1.92 (1.19--6.79)
  GPx U/L      2975 (1266--6967)                         2759 (862--6001)         2587 (690--6036)        2500 (966--5967)         3018 (1552--7243)
  SOD U/ml     157.28 (116.92--350.52)                   147.98 (32.76--277.88)   98.14 (10.0--189.12)    119.48 (13.16--292.36)   128.72 (76.08--170.96)

AAA: p-value \<0.05 HO-1 I/II; I/III; I/IV; I/V; III/V; IV/V, GPx I/III, SOD I/III. AIOD: p-value \<0.05 HO-1 I/II; I/III; I/IV; III/V; IV/V, GPx I/III SOD I/III.
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